Brain-gut-microbe communication in health and disease

Frontiers in Physiology

Volumn 2 DEC, Issue , 2011, Pages

  Grenham, Sue ^a   Clarke, Gerard ^a,b   Cryan, John F ^a,b   Dinan, Timothy G ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Central nervous system; Dysbiosis; Enteric nervous system; Inflammation; Irritable bowel syndrome; Microbiota; Probiotic; Vagus nerve

Indexed keywords

EID: 84860644097     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2011.00094     Document Type: Article

References (175)

1. Abrams, G. D., Bauer, H., and Sprinz, H. (1963). Influence of the normal flora on mucosal morphology and cellular renewal in the ileum. A comparison of germ-free and conventional mice. Lab. Invest. 12, 355-364.
2. Adlerberth, I., and Wold, A. E. (2009). Establishment of the gut microbiota in Western infants. Acta Paediatr. 98, 229-238.
3. Akira, S., and Hemmi, H. (2003). Recognition of pathogen-associated molecular patterns by TLR family. Immunol. Lett. 85, 85-95.
4. American Psychiatric Association. (2000). "Diagnostic criteria for 299.00 Autistic Disorder, " in Diagnostic and Statistical Manual of Mental Disorders. 4th, text revision. (DSM-IV-TR). Washington DC: American Psychiatric Association.
5. Andus, T., and Gross, V. (2000). Etiology and pathophysiology of inflammatory bowel disease - Environmental factors. Hepatogastroenterology 47, 29-43.
6. Aragon, G., Graham, D. B., Borum, M., and Doman, D. B. (2010). Probiotic therapy for irritable bowel syndrome. Gastroenterol. Hepatol.. (N.Y.) 6, 39-44.
7. Archie, E. A., and Theis, K. R. (2011). Animal behaviour meets microbial ecology. Anim. Behav. 82, 425-436.
8. Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., and Gordon, J. I. (2004). The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. U.S.A. 101, 15718-15723.
9. Bäckhed, F., Manchester, J. K., Semenkovich, C. F., and Gordon, J. I. (2007). Mechanisms underlying the resistance to dietinduced obesity in germ-free mice. Proc. Natl. Acad. Sci. U.S.A. 104, 979-984.
10. Bailey, M. T., and Coe, C. L. (1999). Maternal separation disrupts the integrity of the intestinal microflora in infant rhesus monkeys. Dev. Psychobiol. 35, 146-155.
11. Bailey, M. T., Engler, H., and Sheridan, J. E. (2006). Stress induces the translocation of cutaneous and gastrointestinal microflora to secondary lymphoid organs of C57BL/6 mice. J. Neuroimmunol. 171, 29-37.
12. Bailey, M. T., Lubach, G. R., and Coe, C. L. (2004). Prenatal stress alters bacterial colonization of the gut in infant monkeys.J. Pediatr. Gastroenterol. Nutr. 38, 414-421.
13. Barbara, G., Stanghellini, V., De Giorgio, R., Cremon, C., Cottrell, G. S., Santini, D., Pasquinelli, G., Morselli-Labate, A. M., Grady, E. F., Bun-nett, N. W., Collins, S. M., and Corinaldesi, R. (2004). Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroen-terology 126, 693-702.
14. Beaver, M. H., and Wostmann, B. (1962). Histamine and 5-hydroxytryptamine in the intestinal tract of germ-free animals, animals harbouring one microbial species and conventional animals. Br. J. Pharmacol. Chemother. 19, 385.
15. Bennet, R., Eriksson, M., and Nord, C. E. (2002). The fecal microflora of 1-3-month-old infants during treatment with eight oral antibiotics. Infection 30, 158-160.
16. Bercik, P., Denou, E., Collins, J., Jackson, W., Lu, J., Jury, J., Deng, Y., Blennerhassett, P., Macri, J., Mccoy, K. D., Verdu, E. F., and Collins, S. M. (2011). The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 141, 599-609.
17. Berg, R. D. (1996). The indigenous gastrointestinal microflora. Trends Microbiol. 4, 430-435.
18. Bischoff, S.C. (2010).'Guthealth':a new objective in medicine? BMCMed. 9, 24.
19. Bloom, S. M., Bijanki, V. N., Nava, G. M., Sun, L., Malvin, N. P., Donermeyer, D. L., Dunne, W. M. Jr., Allen, P. M., and Stappenbeck, T. S. (2011). Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease. Cell Host Microbe 9, 390-403.
20. Bloom, S. R., Kuhajda, E P., Laher, I., Pi-Sunyer, X., Ronnett, G. V., Tan, T. M. M., and Weigle, D. S. (2008). The obesity epidemic pharmacological challenges. Mol. Interv. 8, 82-98.
21. Blumberg, R. S., and Strober, W. (2001). Prospects for research in inflammatory bowel disease. J. Am. Med. Assoc. 285, 643-647.
22. Bolte, E.R. (1998). Autism and Clostridium tetani. Med. Hypotheses 51, 133-144.
23. Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., and Cryan, J. E. (2011). Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc. Natl. Acad. Sci.
24. Brenner, D. M., Moeller, M. J., Chey, W. D., and Schoenfeld, P. S. (2009). The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review. Am. J. Gastroenterol. 104, 1033-1049; quiz 1050.
25. Brint, E. K., Macsharry, J., Fanning, A., Shanahan, F., and Quigley, E. M. M. (2011). Differential expression of toll-like receptors in patients with irritable bowel syndrome. Am. J. Gastroenterol. 106, 329-336.
26. Camilleri, M. (2001). Management of the irritable bowel syndrome. Gastroenterology 120, 652-668.
27. Cario, E., Gerken, G., and Podolsky, D. K. (2004). Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology 127, 224-238.
28. Cash, H. L., Whitham, C. V., Behrendt, C. L., and Hooper, L. V. (2006). Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 313, 1126-1130.
29. Cenac, N., Andrews, C. N., Holzhausen, M., Chapman, K., Cottrell, G., Andrade-Gordon, P., Steinhoff, M., Barbara, G., Beck, P., Bunnett, N. W., Sharkey, K. A., Ferraz, J. G. P., Shaffer, E., and Vergnolle, N. (2007). Role for protease activity in visceral pain in irritable bowel syndrome. J. Clin. Invest. 117, 636-647.
30. Chadwick, V. S., Chen, W., Shu, D., Paulus, B., Bethwaite, P., Tie, A., and Wilson, I. (2002). Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 122, 1778-1783.
31. Claesson, M. J., Cusack, S., O'Sullivan, O., Greene-Diniz, R., De Weerd, H., Flannery, E., Marchesi, J. R., Falush, D., Dinan, T., Fitzgerald, G., Stanton, C., Van Sinderen, D., O'Connor, M., Harnedy, N., O'Connor, K., Henry, C., O'Mahony, D., Fitzgerald, A. P., Shanahan, F., Twomey, C., Hill, C., Ross, R. P., and O'Toole, P. W. (2011). Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc. Natl. Acad. Sci. U.S.A. 108(SUPPL. 1), 4586-4591.
32. Clarke, G., Fitzgerald, P., Hennessy, A. A., Cassidy, E. M., Quigley, E. M., Ross, P., Stanton, C., Cryan, J. F., and Dinan, T. G. (2010). Marked elevations in pro-inflammatory polyunsaturated fatty acid metabolites in females with irritable bowel syndrome. J. Lipid Res. 51, 1186-1192.
33. Clarke, G., O'Mahony, S. M., Hennessy, A. A., Ross, P., Stanton, C., Cryan, J. F., and Dinan, T. G. (2009a). Chain reactions: early-life stress alters the metabolic profile of plasma polyunsaturated fatty acids in adulthood. Behav. Brain Res. 205, 319-321.
34. Clarke, G., Quigley, E. M., Cryan, J. F., and Dinan, T. G. (2009b). Irritable bowel syndrome: towards biomarker identification. Trends. Mol. Med. 15, 478-489.
35. Clayton, E. M., Rea, M. C., Shanahan, F., Quigley, E. M., Kiely, B., Hill, C., and Ross, R. P. (2009). The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission. Am. J. Gastroenterol. 104, 1162-1169.
36. Codling, C., O'Mahony, L., Shanahan, F., Quigley, E., and Marchesi, J. (2010). A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome. Dig. Dis. Sci. 55, 392-397.
37. Collins, S. M. (2002). A case for an immunological basis for irritable bowel syndrome. Gastroenterology 122, 2078-2080.
38. Collins, S. M., Denou, E., Verdu, E. F., and Bercik, P. (2009). The putative role of the intestinal microbiota in the irritable bowel syndrome. Dig. Liver Dis. 41, 850-853.
39. Corr, S. C., Gahan, C. G. M., and Hill, C. (2007a). Impact of selected Lactobacillus and Bifidobacterium species on Listeria monocytogenes infection and the mucosal immune response. FEMS Immunol. Med. Microbiol. 50, 380-388.
40. Corr, S. C., Li, Y., Riedel, C. U., O'Toole, P. W., Hill, C., and Gahan, C. G. M. (2007b). Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc. Natl. Acad. Sci. U.S.A. 104, 7617-7621.
41. Cryan, J. F., and O'Mahony, S. M. (2011). The microbiome-gut-brain axis: from bowel to behavior. Neurogastroenterol. Motil. 23, 187-192.
42. Demaude, J., Salvador-Cartier, C., Fioramonti, J., Ferrier, L., and Bueno, L. (2006). Phenotypic changes in colonocytes following acute stress or activation of mast cells in mice: implications for delayed epithelial barrier dysfunction. Gut 55, 655-661.
43. Desbonnet, L., Garrett, L., Clarke, G., Bienenstock, J., and Dinan, T. G. (2008). The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat. J. Psychiatr. Res. 43, 164-174.
44. Desbonnet, L., Garrett, L., Clarke, G., Kiely, B., Cryan, J. F., and Dinan, T. G. (2010). Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience 170, 1179-1188.
45. Dinan, T. G., Clarke, G., Quigley, E. M., Scott, L. V., Shanahan, F., Cryan, J., Cooney, J., and Keeling, P. W. (2008). Enhanced cholinergic-mediated increase in the pro-inflammatory cytokine IL-6 in irritable bowel syndrome: role of muscarinic receptors. Am. J. Gastroenterol. 103, 2570-2576.
46. Dinan, T. G., Quigley, E. M., Ahmed, S. M., Scully, P., O'Brien, S., O'Mahony, L., O'Mahony, S., Shanahan, F., and Keeling, P. W. (2006). Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology 130, 304-311.
47. Donskey, C. J., Hujer, A. M., Das, S. M., Pultz, N. J., Bonomo, R. A., and Rice, L. B. (2003). Use of denaturing gradient gel electrophoresis for analysis of the stool microbiota of hospitalized patients. J. Microbiol Methods 54, 249-256.
48. Drossman, D. A., Camilleri, M., Mayer, E. A., and Whitehead, W. E. (2002). AGA technical review on irritable bowel syndrome. Gastroenterology 123, 2108-2131.
49. Dunlop, S. P., Jenkins, D., Neal, K. R., and Spiller, R. C. (2003). Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology 125, 1651-1659.
50. Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., and Relman, D. A. (2005). Diversity of the human intestinal microbial flora. Science 308, 1635-1638.
51. Ewaschuk, J. B., Diaz, H., Meddings, L., Diederichs, B., Dmytrash, A., Backer, J., Looijer-Van Langen, M., and Madsen, K. L. (2008). Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am. J. Physiol. Gastrointest. Liver Physiol. 295, G1025-G1034.
52. Finegold, S. M. (2008). Therapy and epidemiology of autism-clostridial spores as key elements. Med. Hypotheses 70, 508-511.
53. Finegold, S. M., Dowd, S. E., Gontcharova, V., Liu, C., Henley, K. E., Wolcott, R. D., Youn, E., Summanen, P. H., Granpeesheh, D., Dixon, D., Liu, M., Molitoris, D.R., and Green Iii, J. A. (2010). Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe 16, 444-453.
54. Finegold, S. M., Molitoris, D., Song, Y., Liu, C., Vaisanen, M. L., Bolte, E., Mcteague, M., Sandler, R., Wexler, H., and Marlowe, E. M. (2002). Gastrointestinal microflora studies in late-onset autism. Clin. Infect. Dis. 35, S6.
55. Forsythe, P., Sudo, N., Dinan, T., Taylor, V. H., andBienenstock, J. (2010). Mood and gut feelings. Brain Behav. Immun. 24, 9-16.
56. Frank, D. N., St Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., and Pace, N. R. (2007). Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. U.S.A. 104, 13780-13785.
57. Freestone, P. P., Williams, P. H., Haigh, R. D., Maggs, A. F., Neal, C. P., and Lyte, M. (2002). Growth stimulation of intestinal commensal Escherichia coli by catecholamines: a possible contributory factor in traumainduced sepsis. Shock 18, 465-470.
58. Freestone, P. P. E., Haigh, R. D., Williams, P. H., and Lyte, M. (2003). Involvement of enterobactin in norepinephrine-mediated iron SUPPLy from transferrin to entero-haemorrhagic Escherichia coli. FEMS Microbiol. Lett. 222, 39-43.
59. Gareau, M. G., Wine, E., Rodrigues, D.M., Cho, J. H., Whary, M. T., Philpott, D. J., Macqueen, G., and Sherman, P. M. (2011). Bacterial infection causes stress-induced memory dysfunction in mice. Gut 60, 307-317.
60. Gill, S. R., Pop, M., Deboy, R. T., Eckburg, P. B., Turnbaugh, P. J., Samuel, B. S., Gordon, J. I., Relman, D. A., Fraser-Liggett, C. M., and Nelson, K. E. (2006). Metagenomic analysis of the human distal gut microbiome. Science 312, 1355-1359.
61. Glaister, J. (1973). Factors affecting the lymphoid cells in the small intestinal epithelium of the mouse. Int. Arch. Allergy Immunol. 45, 719-730.
62. Gordon, H. A. (1959). Morphological and physiological characterization of germfree life. Ann. N. Y. Acad. Sci. 78, 208-220.
63. Gordon, H. A., and Bruckner-Kardoss, E. (1961). Effect of normal microbial flora on intestinal surface area. Am.J. Physiol. 201, 175.
64. Greer, J. B., and O'Keefe, S. J. (2011). Microbial induction of immunity, inflammation, and cancer. Front. Physiol. 1:168.
65. Guarner, F., Ellen Sanders, M., Gibson, G., Klaenhammer, T., Cabana, M., Scott, K., Reid, G., Delzenne, N. M., Fahey, G. C., and Hill, C. (2011). Probiotic and prebiotic claims in Europe: seeking a clear roadmap. Br. I Nutr. 1, 1-3.
66. Gwee, K., Collins, S., Read, N., Rajnakova, A., Deng, Y., Graham, J., Mckendrick, M., and Moochhala, S. (2003). Increased rectal mucosal expression of interleukin 1 in recently acquired post-infectious irritable bowel syndrome. Gut 52, 523.
67. Gwee, K., Leong, Y., Graham, C., Mckendrick, M., Collins, S., Walters, S., Underwood, J., and Read, N. (1999). The role of psychological and biological factors in postinfective gut dysfunction. Gut 44, 400.
68. Haslam, D. W., and James, W P. T. (2005). Obesity. Lancet 366, 1197-1209.
69. Heijtz, R. D., Wang, S., Anuar, F., Qian, Y., Bjorkholm, B., Samuelsson, A., Hibberd, M. L., Forssberg, H., and Pettersson, S. (2011). Normal gut microbiota modulates brain development and behavior. Proc. Natl. Acad. Sci. U.S.A. 108, 3047-3052.
70. Heuvelin, E., Lebreton, C., Bichara, M., Cerf-Bensussan, N., and Heyman, M. (2009). ABifidobacteriumprobiotic strain and its soluble factors alleviate chloride secretion by human intestinal epithelial cells. J. Nutr. 140, 7-11.
71. Hong, K. S., Kang, H. W., Im, J. P., Ji, G. E., Kim, S. G., Jung, H. C., Song, I. S., and Kim, J. S. (2009). Effect of probiotics on symptoms in Korean adults with irritable bowel syndrome. Gut Liver 3, 101-107.
72. Hong, Y S., Hong, K. S., Park, M. H., Ahn, Y T., Lee, J. H., Huh, C. S., Lee, J., Kim, I. K., Hwang, G. S., andKim, J.S. (2011). Metabonomic understanding of probiotic effects in humans with irritable bowel syndrome. J. Clin. Gastroenterol. 45, 415-425.
73. Hooper, L. V., Stappenbeck, T. S., Hong, C. V., and Gordon, J. I. (2003). Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat. Immunol. 4, 269-273.
74. Hooper, L. V., Wong, M. H., Thelin, A., Hansson, L., Falk, P. G., and Gordon, J. I. (2001). Molecular analysis of commensal host-microbial relationships in the intestine. Science 291, 881-884.
75. Joossens, M., Huys, G., Cnockaert, M., De Preter, V., Verbeke, K., Rutgeerts, P., Vandamme, P., and Vermeire, S. (2011). Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut 60, 631-637.
76. Kajander, K., Hatakka, K., Poussa, T., Farkkila, M., and Korpela, R. (2005). A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. Aliment. Pharmacol. Ther. 22, 387-394.
77. Kajander, K., Myllyluoma, E., Rajilic-Stojanovic, M., Kyronpalo, S., Rasmussen, M., Jarvenpaa, S., Zoetendal, E. G., De Vos, W M., Vapaatalo, H., and Korpela, R. (2008). Clinical trial: multispecies probiotic SUPPLementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Aliment. Pharmacol. Ther. 27, 48-57.
78. Kassinen, A., Krogius-Kurikka, L., Mäkivuokko, H., Rinttilä, T., Paulin, L., Corander, J., Malinen, E., Apajalahti, J., and Palva, A. (2007). The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 133, 24-33.
79. Kerckhoffs, A. P. M., Samsom, M., Van Der Rest, M. E., De Vogel, J., Knol, J., Ben-Amor, K., and Akkermans, L. M. A. (2009). Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients. World J. Gastroenterol. 15, 2887.
80. Kiliaan, A. J., Saunders, P. R., Bijlsma, P. B., Berin, M. C., Taminiau, J. A., Groot, J. A., and Perdue, M. H. (1998). Stress stimulates transepithelial macromolecular uptake in rat jejunum. Am. J. Physiol. 275, G1037-G1044.
81. Kopp-Hoolihan, L. (2001). Prophylactic and therapeutic uses of probiotics: a review. J. Am. Diet.Assoc. 101, 229-238; quiz 239-241.
82. Kurokawa, K., Itoh, T., Kuwahara, T., Oshima, K., Toh, H., Toy-oda, A., Takami, H., Morita, H., Sharma, V. K., and Srivastava, T. P. (2007). Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes. DNA Res. 14, 169.
83. Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., and Gordon, J. I. (2005). Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. U.S.A. 102, 11070-11075.
84. Ley, R. E., Peterson, D. A., and Gordon, J. I. (2006a). Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124, 837-848.
85. Ley, R. E., Turnbaugh, P. J., Klein, S., and Gordon, J. I. (2006b). Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022-1023.
86. Lichtenstein, G. R. (2000). Chemokines and cytokines in inflammatory bowel disease and their application to disease treatment. Curr. Opin. Gastroenterol. 16, 83-88.
87. Liebregts, T., Adam, B., Bredack, C, Roth, A., Heinzel, S., Lester, S., Downie-Doyle, S., Smith, E., Drew, P., Talley, N. J., and Holtmann, G. (2007). Immune activation in patients with irritable bowel syndrome. Gastroenterology 132, 913-920.
88. Lupp, C., Robertson, M. L., Wickham, M. E., Sekirov, I., Champion, O. L., Gaynor, E. C., and Finlay, B. B. (2007). Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2, 204.
89. Lyra, A., Krogius-Kurikka, L., Nikkila, J., Malinen, E., Kajander, K., Kurikka, K., Korpela, R., and Palva, A. (2010). Effect of a multispecies probiotic SUPPLement on quantity of irritable bowel syndromerelated intestinal microbial phylotypes. BMC Gastroenterol. 10, 110.
90. Lyte, M., Li, W., Opitz, N., Gaykema, R., and Goehler, L. E. (2006). Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyper-plasia Citrobacter rodentium. Physiol. Behav. 89, 350-357.
91. MacDonald, T. T., and Monteleone, G. (2005). Immunity, inflammation, and allergy in the gut. Science 307, 1920.
92. Macfarlane, G., Blackett, K., Nakayama, T., Steed, H., and Macfarlane, S. (2009). The gut microbiota in inflammatory bowel disease. Curr. Pharm. Des. 15, 1528-1536.
93. Macfarlane, S., and Macfarlane, G. T. (2003). Regulation of short-chain fatty acid production. Proc. Nutrition Soc. 62, 67-72.
94. Mackie, R. I., Sghir, A., and Gaskins, H. R. (1999). Developmental microbial ecology of the neonatal gastrointestinal tract. Am. J. Clin. Nutr. 69, 1035S-1045S.
95. Malinen, E., Rinttila, T., Kajander, K., Matto, J., Kassinen, A., Krogius, L., Saarela, M., Korpela, R., and Palva, A. (2005). Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am. J. Gastroenterol. 100, 373-382.
96. Mändar, R., and Mikelsaar, M. (1996). Transmission of mother's microflora to the newborn at birth. Neonatology 69, 30-35.
97. Mangell, P., Nejdfors, P., Wang, M., Ahrne, S., Westrom, B., Thorlacius, H., and Jeppsson, B. (2002). Lac-tobacillus plantarum 299v inhibits Escherichia coli-induced intestinal permeability. Dig. Dis. Sci. 47, 511-516.
98. Marshall, J. K., Thabane, M., Borgaonkar, M.R., and James, C. (2007). Postinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen. Clin. Gastroenterol. Hepatol. 5, 457-460.
99. Marshall, J. K., Thabane, M., Garg, A. X., Clark, W. F., Salvadori, M., and Collins, S. M. (2006). Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology 131, 445-450.
100. Marteau, P. (2010). Probiotics in functional intestinal disorders and IBS: proof of action and dissecting the multiple mechanisms. Gut 59, 285-286.
101. Matsumoto, S., Setoyama, H., and Umesaki, Y. (1992). Differential induction of major histocompatibility complex molecules on mouse intestine by bacterial colonization. Gastroenterology 103, 1777.
102. Mättö, J., Maunuksela, L., Kajander, K., Palva, A., Korpela, R., Kassinen, A., and Saarela, M. (2005). Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome - a longitudinal study in IBS and control subjects. FEMS Immunol. Med. Microbiol. 43, 213-222.
103. Mawdsley, J. E., and Rampton, D. S. (2006). The role of psychological stress in inflammatory bowel disease. Neuroimmunomodulation 13, 327-336.
104. Mayer, E. A. (2011). Gut feelings: the emerging biology of gut-brain communication. Nat. Rev. Neurosci. 12, 453-466.
105. Mayer, L. (2003). Mucosal immunity. Pediatrics 111, 1595-1600.
106. Mazmanian, S. K., Liu, C. H., Tzianabos, A. O., and Kasper, D. L. (2005). An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122, 107-118.
107. McCracken, V. J., and Lorenz, R. G. (2001). The gastrointestinal ecosystem: a precarious alliance among epithelium, immunity and microbiota. Cell. Microbiol. 3, 1-11.
108. McKernan, D. P., Fitzgerald, P., Dinan, T. G., and Cryan, J. F. (2010). The probiotic Bifidobacterium infantis 35624 displays visceral antinoci-ceptive effects in the rat. Neurogastroenterol Motil. 22, 1029-1035, e1268.
109. McKernan, D. P., Gaszner, G., Quigley, E. M., Cryan, J. F., and Dinan, T. G. (2011). Altered peripheral toll-like receptor responses in the irritable bowel syndrome. Aliment. Pharmacol. Ther. 33, 1045-1052.
110. Melgar, S., and Shanahan, F. (2010). Inflammatory bowel disease-from mechanisms to treatment strategies. Autoimmunity 43, 463-477.
111. Messaoudi, M., Lalonde, R., Violle, N., Javelot, H., Desor, D., Nejdi, A., Bisson, J. F., Rougeot, C., Pichelin, M., Cazaubiel, M., and Cazaubiel, J. M. (2011). Assessment of psychotropic-like properties of a probiotic formulation. (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br. J. Nutr. 105, 755-764.
112. Mikkelsen, H. B., Garbarsch, C., Tranum-Jensen, J., and Thuneberg, L. (2004). Macrophages in the small intestinal muscularis externa of embryos, newborn and adult germ-free mice. J. Mol. Histol. 35, 377-387.
113. Million, M., Maraninchi, M., Henry, M., Armougom, F., Richet, H., Carrieri, P., Valero, R., Raccah, D., Vialettes, B., and Raoult, D. (2011). Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii. Int. J. Obes.. (Lond.).
114. Moayyedi, P., Ford, A. C., Talley, N. J., Cremonini, F., Foxx-Orenstein, A. E., Brandt, L. J., and Quigley, E. M. (2008). The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut 59, 325-332.
115. Moreau, M. C., Ducluzeau, R., Guy-Grand, D., and Muller, M. C. (1978). Increase in the population of duodenal immunoglobulin a plasmocytes in axenic mice associated with different living or dead bacterial strains of intestinal origin. Infect. Immun. 21, 532-539.
116. Neufeld, K. M., Kang, N., Bienenstock, J., and Foster, J. A. (2011). Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol. Motil. 23, 255-264.
117. O'Hara, A. M., and Shanahan, F. (2006). The gut flora as a forgotten organ. EMBO Rep. 7, 688-693.
118. O'Mahony, L., Mccarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K., O'Sullivan, G. C., Kiely, B., Collins, J. K., Shanahan, F., and Quigley, E. M. (2005). Lactobacillus and Bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 128, 541-551.
119. O'Mahony, S. M., Hyland, N. P., Dinan, T. G., and Cryan, J. F. (2011). Maternal separation as a model of brain-gut axis dysfunction. Psychopharmacology. (Berl.) 214, 71-88.
120. O'Mahony, S. M., Marchesi, J. R., Scully, P., Codling, C., Ceolho, A. M., Quigley, E. M., Cryan, J. F., and Dinan, T. G. (2009). Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol. Psychiatry 65, 263-267.
121. Palmer, C., Bik, E. M., Digiulio, D. B., Relman, D. A., and Brown, P. O. (2007). Development of the human infant intestinal microbiota. PLoS Biol. 5, e177.
122. Pandol, S. J. (2010). Integrating the gastrointestinal sciences. Front. Physiol. 1:19.
123. Parracho, H. M., Bingham, M. O., Gibson, G. R., and Mccartney, A. L. (2005). Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J. Med. Microbiol. 54, 987-991.
124. Parvez, S., Malik, K. A., Ah Kang, S., and Kim, H. Y. (2006). Probiotics and their fermented food products are beneficial for health. J. Appl. Microbiol. 100, 1171-1185.
125. Podolsky, D. K. (2002). Inflammatory bowel disease. N Engl. J. Med. 347, 417-429.
126. Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., Yamada, T., Mende, D. R., Li, J., Xu, J., Li, S., Li, D., Cao, J., Wang, B., Liang, H., Zheng, H., Xie, Y., Tap, J., Lepage, P., Bertalan, M., Batto, J.-M., Hansen, T., Le Paslier, D., Lin-neberg, A., Nielsen, H. B., Pelletier, E., Renault, P., Sicheritz-Ponten, T., Turner, K., Zhu, H., Yu, C., Li, S., Jian, M., Zhou, Y., Li, Y., Zhang, X., Li, S., Qin, N., Yang, H., Wang, J., Brunak, S., Dore, J., Guarner, F., Kristiansen, K., Pedersen, O., Parkhill, J., Weissenbach, J., Bork, P., Ehrlich, S. D., and Wang, J. (2010). A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59-65.
127. Quigley, E. M. (2007). Bacterial flora in irritable bowel syndrome: role in pathophysiology, implications for management. J. Dig. Dis. 8, 2-7.
128. Quigley, E. M. (2008). Probiotics in functional gastrointestinal disorders: what are the facts? Curr. Opin. Pharmacol. 8, 704-708.
129. Quigley, E. M. (2009). Do patients with functional gastrointestinal disorders have an altered gut flora? Therap. Adv. Gastroenterol. 2, 23-30.
130. Quigley, E. M. M. (2011). Antibiotics in irritable bowel syndrome: a novel approach to a challenging disorder. Clin. Investig.. (Lond.) 1, 479-482.
131. Rajilic-Stojanovic, M., Biagi, E., Heilig, H. G. H. J., Kajander, K., Kekkonen, R. A., Tims, S., and De Vos, W. M. (2011). Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 141, 1792-1801.
132. Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., and Medzhitov, R. (2004). Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118, 229-241.
133. Reber, S. O. (2011). Stress and animal models of inflammatory bowel disease - An update on the role of the hypothalamo-pituitary-adrenal axis. Psychoneuroendocrinology. doi:10.1016/j.psyneuen.2011.05.014
134. Rhee, S. H., Pothoulakis, C., and Mayer, E. A. (2009). Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat. Rev. Gastroenterol. Hepatol. 6, 306-314.
135. Rodríguez, L. A. G., and Ruigómez, A. (1999). Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study. BMJ 318, 565.
136. Rousseaux, C., Thuru, X., Gelot, A., Barnich, N., Neut, C., Dubuquoy, L., Dubuquoy, C., Merour, E., Geboes, K., Chamaillard, M., Ouwehand, A., Leyer, G., Carcano, D., Colombel, J. F., Ardid, D., and Desreumaux, P. (2007). Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat. Med. 13, 35-37.
137. Ruddick, J. P., Evans, A. K., Nutt, D. J., Lightman, S. L., Rook, G. A., and Lowry, C. A. (2006). Tryptophan metabolism in the central nervous system: medical implications. Expert Rev. Mol. Med. 8, 1-27.
138. Samuel, B. S., Shaito, A., Motoike, T., Rey, E E., Backhed, F., Manchester, J. K., Hammer, R. E., Williams, S. C., Crowley, J., Yanagisawa, M., and Gordon, J. I. (2008). Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc. Natl. Acad. Sci. U.S.A. 105, 16767-16772.
139. Sandler, R. H., Finegold, S. M., Bolte, E. R., Buchanan, C. P., Maxwell, A. P., Väisänen, M.-L., Nelson, M. N., and Wexler, H. M. (2000). Short-term benefit from oral vancomycin treatment of regressive-onset autism. J. Child Neurol. 15, 429-435.
140. Sarna, S.K. (2011). Lessons learnt from post-infectious IBS. Front. Physiol. 2:49.
141. Scanlan, P. D., Shanahan, F., O'Mahony, C., and Marchesi, J. R. (2006). Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease. J. Clin. Microbiol. 44, 3980-3988.
142. Schellekens, H., Dinan, T. G., and Cryan, J. F. (2010). Lean mean fat reducing "ghrelin" machine: hypothalamic ghrelin and ghrelin receptors as therapeutic targets in obesity. Neuropharmacology 58, 2-16.
143. Scully, P., McKernan, D. P., Keo-hane, J., Groeger, D., Shanahan, E, Dinan, T. G., and Quigley, E. M. (2010). Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal comorbidity. Am. J. Gastroenterol. 105, 2235-2243.
144. Sekirov, I., Russell, S. L., Antunes, L. C. M., and Finlay, B. B. (2010). Gut microbiota in health and disease. Physiol. Rev. 90, 859-904.
145. Shanahan, E. (2002). The host-microbe interface within the gut. Best Pract. Res. Clin. Gastroenterol. 16, 915-931.
146. Shanahan, F. (2004). Probiotics in inflammatory bowel disease - therapeutic rationale and role. Adv. Drug Deliv. Rev. 56, 809-818.
147. Shanahan, E. (2005). Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases I. Pathophysiological basis and prospects for probiotic therapy in inflammatory bowel disease. Am. J. Physiol. Gastrointest. Liver Physiol. 288, G417-G421.
148. Shanahan, E. (2010a). Gut microbes: from bugs to drugs. Am. J. Gastroenterol. 105, 275-279.
149. Shanahan, E. (2010b). Probiotics in perspective. Gastroenterology 139, 1808-1812.
150. Smith, K., Mccoy, K. D., and Macpher-son, A. J. (2007). Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota. Semin. Immunol. 19, 59-69.
151. Sobko, T., Reinders, C., Norin, E., Midtvedt, T., Gustafsson, L. E., and Lundberg, J. O. (2004). Gastrointestinal nitric oxide generation in germ-free and conventional rats. Am. J. Physiol. Gastrointest. Liver Physiol. 287, G993.
152. Sokol, H., Seksik, P., Rigottier-Gois, L., Lay, C., Lepage, P., Podglajen, I., Marteau, P., and Doré, J. (2006). Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm. Bowel Dis. 12, 106-111.
153. Song, Y., Liu, C., and Finegold, S. M. (2004). Real-time PCR quantitation of clostridia in feces of autistic children. Appl. Environ. Microbiol. 70, 6459-6465.
154. Spiller, R., and Garsed, K. (2009). Postinfectious irritable bowel syndrome. Gastroenterology 136, 1979-1988.
155. Spiller, R. C., Jenkins, D., Thornley, J. P., Hebden, J. M., Wright, T., Skinner, M., and Neal, K. R. (2000). Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 47, 804-811.
156. Stappenbeck, T. S., Hooper, L. V., and Gordon, J. I. (2002). Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc. Natl. Acad. Sci. U.S.A. 99, 15451.
157. Sudo, N., Chida, Y., Aiba, Y., Sonoda, J., Oyama, N., Yu, X. N., Kubo, C., and Koga, Y. (2004). Postnatal microbial colonization programs the hypo thalamic-pituitary-adrenal system for stress response in mice. J. Physiol.. (Lond.) 558, 263-275.
158. Sumi, Y., Miyakawa, M., Kanzaki, M., and Kotake, Y. (1977). Vitamin B-6 deficiency in germfree rats. J. Nutr. 107, 1707.
159. Tana, C., Umesaki, Y., Imaoka, A., Handa, T., Kanazawa, M., and Fukudo, S. (2010). Altered profiles of intestinal microbiota and organic acids maybe the origin of symptoms in irritable bowel syndrome. Neurogastroenterol. Motil. 22, 512-519, e114-e115.
160. Thompson, W. G., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J., and Müller-Lissner, S. A. (1999). Functional bowel disorders and functional abdominal pain. Gut 45, II43-II47.
161. Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., and Gordon, J. I. (2006). An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027-1031.
162. Ulevitch, R. J. (1999). Endotoxin opens the Tollgates to innate immunity. Nat. Med. 5, 144-145.
163. Umesaki, Y., Okada, Y., Matsumoto, S., Imaoka, A., and Setoyama, H. (1995). Segmented filamentous bacteria are indigenous intestinal bacteria that activate intraepithelial lymphocytes and induce MHC class II molecules and fucosyl asialo GM1 glycolipids on the small intestinal epithelial cells in the ex-germ-free mouse. Microbiol. Immunol. 39, 555-562.
164. Vaishnava, S., Behrendt, C. L., Ismail, A. S., Eckmann, L., and Hooper, L. V. (2008). Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc. Natl. Acad. Sci. U.S.A. 105, 20858-20863.
165. Verdu, E. F., Bercik, P., Verma-Gandhu, M., Huang, X. X., Blennerhassett, P., Jackson, W., Mao, Y., Wang, L., Rochat, F., and Collins, S. M. (2006). Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut 55, 182-190.
166. Walker, A., Sanderson, J., Churcher, C., Parkes, G., Hudspith, B., Rayment, N., Brostoff, J., Parkhill, J., Dougan, G., and Petrovska, L. (2011). High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiol. 11, 7.
167. Whorwell, P. J. (2009). Do probiotics improve symptoms in patients with irritable bowel syndrome? Therap. Adv. Gastroenterol. 2, 37-44.
168. Willing, B., Halfvarson, J., Dicksved, J., Rosenquist, M., Järnerot, G., Engstrand, L., Tysk, C., and Jans-son, J. K. (2009). Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease. Inflamm. Bowel Dis. 15, 653-660.
169. Woodmansey, E. J. (2007). Intestinal bacteria and ageing. J. Appl. Microbiol. 102, 1178-1186.
170. Wostmann, B., and Bruckner-Kardoss, E. (1959). Development of cecal distention in germ-free baby rats. Am. J. Physiol. 197, 1345-1346.
171. Wostmann, B. S. (1981). The germfree animal in nutritional studies. Annu. Rev. Nutr. 1, 257-279.
172. Wostmann, B. S., Larkin, C., Moriarty, A., and Bruckner-Kardoss, E. (1983). Dietary intake, energy metabolism, and excretory losses of adult male germfree Wistar rats. Lab. Anim. Sci. 33, 46.
173. Wu, S. V., and Hui, H. (2011). Treat your bug right. Front. Physiol. 2:9.
174. Xu, J., Mahowald, M. A., Ley, R. E., Lozupone, C. A., Hamady, M., Martens, E. C., Henrissat, B., Coutinho, P. M., Minx, P., Latreille, P., Cordum, H., Van Brunt, A., Kim, K., Fulton, R. S., Fulton, L. A., Clifton, S. W., Wilson, R. K., Knight, R. D., and Gordon, J. I. (2007). Evolution of symbiotic bacteria in the distal human intestine. PLoS Biol. 5, e156.
175. Zareie, M., Johnson-Henry, K., Jury, J., Yang, P. C., Ngan, B. Y., Mckay, D. M., Soderholm, J. D., Perdue, M. H., and Sherman, P. M. (2006). Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress. Gut 55, 1553-1560.